Leukemia drug found effective in treating MS
Contemporary Long-Term Care Weekly, October 30, 2008
In a recent study conducted by researchers at the University of Cambridge in England, alemtuzumab, a drug designed to treat chronic lymphocytic leukemia, reduced the effects of multiple sclerosis (MS) in participants, according to the results published in the October 23 issue of the New England Journal of Medicine.
Alemtuzumab reduced the number of attacks participants experienced by 74% over interferon beta-1a, the most effective drug currently used in the treatment of MS. Study results also reveal that participants taking alemtuzumab recovered some of their lost functions, leading researchers to believe that the drug allows for the recovery of damaged brain tissue.
Comments
0 comments on “Leukemia drug found effective in treating MS ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
